Hepatitis C virus burden: Treating and educating people without prejudice

Table 1 Patient characteristics at the start of treatment

Characteristic	n = 40
Gender [male; n (%)]	31 (77.5)
Age [yr; median (range)]	46.5 (24-63)
Severity of opioid use disorder
Abstinent, n (%)	16 (40.0)
User, n (%)	21 (52.5)
Abuser, n (%)	3 (7.5)
Concomitant opioid agonist maintenance therapy
Metadone, n (%)	35 (87.5)
Buprenorfine, n (%)	1 (2.5)
None (previous history), n (%)	4 (10.0)
History of alcohol abuse, n (%)	14 (35.0)
Concomitant psychoactive drugs, n (%)	17 (42.5)
HCV genotype
1a, n (%)	21 (52.5)
3, n (%)	18 (45.0)
4, n (%)	1 (2.5)
Liver disease staging1
F0, n (%)	8 (22.9)
F1, n (%)	12 (34.3)
F2, n (%)	6 (17.1)
F3, n (%)	5 (14.3)
F4, n (%)	4 (11.4)

¹Available in 35 cases. Elastography could not be performed in the remaining 5 patients and disease staging was calculated using “Fibrosis 4 Score”. HCV: Hepatitis C virus.